Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Ciro Costagliola, Francesco Morescalchi, Sarah Duse, Davide Romano, Giuseppina Mazza, Francesco Parmeggiani, Silvia Bartollino & Francesco Semeraro. (2019) Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update. Expert Opinion on Drug Safety 18:9, pages 803-815.
Read now
Read now
Jessica Boyle, Meri Vukicevic, Konstandina Koklanis, Catherine Itsiopoulos & Gwyneth Rees. (2018) Experiences of patients undergoing repeated intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration. Psychology, Health & Medicine 23:2, pages 127-140.
Read now
Read now
Focke Ziemssen, Bianka Sobolewska, Heidrun Deissler & Helmut Deissler. (2016) Safety of monoclonal antibodies and related therapeutic proteins for the treatment of neovascular macular degeneration: addressing outstanding issues. Expert Opinion on Drug Safety 15:1, pages 75-87.
Read now
Read now
Chandrakumar Balaratnasingam, Elona Dhrami-Gavazi, Jesse T McCann, Quraish Ghadiali & K Bailey Freund. (2015) Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration. Clinical Ophthalmology 9, pages 2355-2371.
Read now
Read now
Yuka Ito, Yoshitsugu Saishin, Osamu Sawada, Masashi Kakinoki, Taichiro Miyake, Tomoko Sawada, Hajime Kawamura & Masahito Ohji. (2015) Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion. Clinical Ophthalmology 9, pages 175-180.
Read now
Read now
Francesco Semeraro, Andrea Russo, Elena Gambicorti, Sarah Duse, Francesco Morescalchi, Sara Vezzoli & Ciro Costagliola. (2015) Efficacy and vitreous levels of topical NSAIDs. Expert Opinion on Drug Delivery 12:11, pages 1767-1782.
Read now
Read now
Marina A Dobrovolskaia & Scott E McNeil. (2015) Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics. Expert Opinion on Biological Therapy 15:7, pages 1023-1048.
Read now
Read now
Xue-Song Mi, Ti-Fei Yuan, Yong Ding, Jing-Xiang Zhong & Kwok-Fai So. (2014) Choosing preclinical study models of diabetic retinopathy: key problems for consideration. Drug Design, Development and Therapy 8, pages 2311-2319.
Read now
Read now
Articles from other publishers (6)
Yusuke Arai, Hidenori Takahashi, Satoru Inoda, Shinichi Sakamoto, Xue Tan, Yuji Inoue, Satoko Tominaga, Hidetoshi Kawashima & Yasuo Yanagi. (2020) Efficacy of Modified Treat-and-Extend Aflibercept Regimen for Macular Edema Due to Branch Retinal Vein Occlusion: 1-Year Prospective Study. Journal of Clinical Medicine 9:8, pages 2360.
Crossref
Crossref
Tanya Camacho-Villegas, María Mata-González, Walter García-Ubbelohd, Linda Núñez-García, Carolina Elosua, Jorge Paniagua-Solis & Alexei Licea-Navarro. (2018) Intraocular Penetration of a vNAR: In Vivo and In Vitro VEGF165 Neutralization. Marine Drugs 16:4, pages 113.
Crossref
Crossref
Morgan V. Fedorchak, Ian P. Conner, Joel S. Schuman, Anthony Cugini & Steven R. Little. (2017) Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop. Scientific Reports 7:1.
Crossref
Crossref
Morgan V. Fedorchak. 2016. Nano-Biomaterials For Ophthalmic Drug Delivery. Nano-Biomaterials For Ophthalmic Drug Delivery
389
406
.
Isis A. S. Brito, Leandro C. Zacharias & Sérgio Luis G. Pimentel. (2015) Fellow Eye Macular Edema Improvement after Intravitreal Bevacizumab for Radiation Retinopathy. Case Reports in Ophthalmological Medicine 2015, pages 1-3.
Crossref
Crossref
Ying Dai, Zhifeng Wu, Feng Wang, Zhengwei Zhang & Mengxi Yu. (2014) Identification of Chemokines and Growth Factors in Proliferative Diabetic Retinopathy Vitreous. BioMed Research International 2014, pages 1-9.
Crossref
Crossref